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Abstract Zebrafish has earned its place among animal
models of tuberculosis. Its natural pathogen, Mycobacterium
marinum, shares major virulence factors with the human path-
ogen Mycobacterium tuberculosis. In adult zebrafish, which
possess recombination-activated adaptive immunity, it can
cause acute infection or a chronic progressive disease with
containment of mycobacteria in well-structured, caseating
granulomas. In addition, a low-dose model that closely
mimics human latent infection has recently been developed.
These models are used alongside infection of optically trans-
parent zebrafish embryos and larvae that rely on innate immu-
nity and permit non-invasive visualization of the early stages
of developing granulomas that are inaccessible in other animal
models. By microinjecting mycobacteria intravenously or into
different tissues, systemic and localized infections can be in-
duced, each useful for studying particular aspects of early
pathogenesis, such as phagocyte recruitment, granuloma ex-
pansion and maintenance, vascularization of granulomas, and
the phagocyte-mediated dissemination of mycobacteria. This
has contributed to new insights into the mycobacteria-driven
mechanisms that promote granuloma formation, the double-
edged role of inflammation, the mechanisms of macrophage
cell death that favor disease progression, and the host-
protective role of autophagy. As a result, zebrafish models
are now increasingly used to explore strategies for adjunctive
therapy of tuberculosis with host-directed drugs.
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Introduction
Mycobacterium tuberculosis (Mtb) is one of the most success-
ful human pathogens that is estimated to have infected one
third of the human population and to be responsible for nine
million new cases of tuberculosis (TB) in 2013 (WHO Global
Tuberculosis report 2014). Mtb parasitizes macrophages and
can persist for decades as a latent infection inside its human
host [1]. The formation of granulomas is central to the pathol-
ogy of TB and the development of latency [2, 3]. TB granu-
lomas are highly organized host cellular structures that contain
an inner core of infected macrophages and necrotic cell debris
(the caseum) where bacteria persist extracellular. In the sur-
rounding cell layers, other immune cells, including dendritic
cells, neutrophils, and T and B cells, wall off the bacteria
inside the granuloma [2, 4]. A latent infection in granulomas
has the ability to reactivate after many years, and the disease
can be transmitted when granuloma integrity is lost. An
alarming rise in antibiotic resistances and the lack of an effec-
tive vaccine against latent or reactivated TB emphasize the
need for novel therapeutic strategies to control TB [5].
Animal models are indispensable for studying the host and
bacterial factors involved in TB pathology and for evaluating
new drug and vaccine candidates. Important insights into hu-
man TB pathology have been inferred from experimentalMtb
infections in mice, guinea pigs, rabbits, and non-human pri-
mates, particularly macaques [6, 7]. In addition, now for over
10 years, the zebrafish has become widely used as an alterna-
tive animal model for TB [8–10]. Zebrafish can be infected
with Mycobacterium marinum (Mm), a natural pathogen of
cold-blooded vertebrates. The genomes ofMtb andMm share
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3000 orthologs with an average amino acid identity of 85 %
[11]. Mm occasionally causes a granulomatous skin infection
in humans known as Bfish tank granuloma^ [12]. In zebrafish,
Mm causes a systemic disease with containment of bacteria in
granulomas that show strong structural similarity with the hu-
man TB granuloma [13–15]. Although differences in the ad-
aptation ofMtb andMm to different hosts must not be ignored,
the important virulence factors ofMtb are functionally able to
complement mutations in Mm genes and vice versa [16, 17].
Studies using the zebrafish-Mm model have contributed
importantly to the changed view of the role of the granuloma
in TB pathogenesis that has emerged over the recent years [2,
10]. Historically, the granuloma has been regarded as a static
host defense structure. However, granuloma formation is driv-
en by bacterial virulence, and it is now widely accepted that
granulomas are highly dynamic structures that, especially dur-
ing early stages of pathogenesis, can promote the dissemina-
tion of mycobacteria [2, 18].Work in zebrafish has shown that
the presence of macrophages is sufficient to initiate granuloma
formation [19]. This means that the early stages of granuloma
formation can be observed in optically transparent zebrafish
embryos and larvae that have a functional innate immune
system but have not yet developed adaptive immunity. The
use of these zebrafish early life stages has shown that second-
ary granulomas can be seeded by the egression of infected
macrophages from a primary granuloma [20]. That granulo-
mas are not impenetrable is evidenced by experiments with
superinfecting mycobacteria that are found to be transported
by infected macrophages into established granulomas. This
was initially observed during Mm infection of zebrafish and
frogs and has subsequently been confirmed duringMtb infec-
tion in mice [21, 22]. Intravital imaging in both zebrafish and
mice has demonstrated the migration of immune cells
throughout the process of granuloma development [20, 23].
The heterogeneity and dynamic nature of granulomas ob-
served in zebrafish andmice is in perfect agreement with serial
PET-CT imaging data from Mtb-infected cynomolgus ma-
caques showing that individual granulomas within the same
host can regress and even be sterilized, while other granulo-
mas progress during the same time [24]. This review will
discuss how studies either in adult zebrafish or in embryos
and larvae have advanced our understanding of mycobacterial
virulence factors and of host genes implicated in immune
protection or TB pathogenesis.
TB in adult zebrafish
While entry via de gastrointestinal tract is most likely the
primary route of Mm infection in the natural environment,
experimental infection of adult zebrafish is commonly
achieved by intraperitoneal injection [13–15, 25]. Dependent
on the particular dose and strain, the infection manifests with
acute symptoms or develops as a chronic progressive disease
[13–15]. Acute disease is characterized by rapid lethal in-
flammation and is more frequently observed with human-
derived isolates of Mm that form a distinct genetic cluster
[14]. Swelling of the abdomen, hemorrhages, and skin ul-
cerations are typically observed at the end stage of the
chronic progressive disease [14]. This is associated with a
strong induction of immune response genes and inflamma-
tion markers at the transcriptional level [26–28]. Well before
external symptoms become apparent, well-organized granu-
lomas are formed in different organs, including the liver,
pancreas, kidney, intestines, and spleen and sometimes also
in the connective tissues [13–15, 29]. Some intraperitoneally
infected zebrafish also develop granulomas in close relation
with brain tissue and meninges; therefore, the model can
also be used to study TB meningitis [30].
Granulomas in adult zebrafish consist of tightly packed
epithelial cells surrounding a central region where macro-
phages are the predominant cell type and mycobacteria are
detectable by acid-fast staining [14]. Importantly, most gran-
ulomas in zebrafish show necrosis in the central core, and
many are hypoxic [14, 15, 31]. Central necrosis is a hallmark
feature of the human TB granuloma that has been difficult to
reproduce in mouse and can be mimicked only in some newer
mouse models of TB [32–34]. In addition, mature granulomas
in zebrafish often are multi-centric and surrounded by a fi-
brous capsule [35]. Calcification of granulomas has not been
observed in zebrafish, and their granulomas contain much less
lymphocytes than those of human TB patients [15, 30]. De-
spite this lower number of lymphocytes, the function of adap-
tive immunity is critical for controlling TB in zebrafish since
mutants in rag1 are hypersusceptible to Mm infection [15].
The chronic progressive zebrafish infection model has proven
useful for antimycobacterial drug screening as well as for
testing of host-targeted drugs [31, 36]. Reducing vasculariza-
tion of zebrafish granulomas by pharmacological inhibition of
vascular endothelial growth factor (Vegf) signaling decreases
overall infection burden, and fish display an increased fre-
quency of sterilized granulomas [31]. Together with a study
of Mtb-infected rabbits, this suggests the potential use of
antiangiogenic drugs in combination with anti-TB drugs for
treatment of TB patients [37].
The study of mechanisms underlying latency and reac-
tivation of TB is hampered by the limitations of animal
models. Recently, it has been shown that the zebrafish-Mm
model can be used to mimic aspects of latent disease [35].
Several weeks after intraperitoneal injection with a low-
dose of Mm bacteria, zebrafish developed stable bacterial
loads and constant numbers of granulomas. Ex vivo acti-
vation by resuscitation promoting factor demonstrated the
dormancy of Mm under these conditions. The develop-
ment of latency relies on rag1-mediated adaptive immuni-
ty, and immunosuppression induced by gamma irradiation
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leads to reactivation of the dormant bacterial population.
This model has much potential for preclinical testing of
new drug and vaccine candidates. As a proof-of-principle,
BCG vaccination and DNA vaccination with different my-
cobacterial antigens were shown to protect zebrafish from
Mm infection in this model [38]. Zebrafish are not easily
inbred, and therefore, large variations are often observed
in studies using this model [39, 40]. However, the natural
heterogeneity of the zebrafish population has been taken
advantage of to gain understanding of genetic differences
that are associated with the ability of individuals to control
latent infection or that pose risk factors for reactivation
[40]. This study showed that zebrafish individuals with
well-controlled infection display not only an efficient
Th1 immune response but also an adequate Th2 response.
Zebrafish heterozygous for a mutation in furinA, encoding
a proprotein convertase of Th1 cells, showed reduced my-
cobacterial load in the latency model, suggesting
proprotein convertase inhibitors as potential drugs for TB
[41].
A number of mutants in mycobacterial virulence genes
have been tested in adult zebrafish [42–47]. Mtb and Mm
use type VII secretion systems, named ESX-1 to ESX-5, to
secrete proteins across their lipid-rich cell wall [48]. The
ESX-1 system is a major virulence factor and absent in
attenuated strains that carry the so-called RD1 deletion
(ΔRD1), including the live vaccine strain Mycobacterium
bovis BCG [49]. In zebrafish, several ΔRD1 Mm strains
showed decreased virulence, supporting the usefulness of
the fish model for TB [15, 42]. Infection with ΔRD1 Mm
has been shown to delay the kinetics of granuloma forma-
tion, resulting in solitary and loose macrophage aggregates
and very few necrotizing granulomas [15]. Similarly, as
discussed further below, ΔRD1 delays the kinetics of gran-
uloma formation in zebrafish embryos that only possess an
innate immune system. However, in the case of an ESX-5
mutant, marked differences were observed between infec-
tions in zebrafish embryos and adults [29]. The ESX-5 se-
cretion system is required for transport of proteins of the PE
and PPE families, of which the functions remain largely
unknown [48]. While ESX-5-deficient Mm is slightly atten-
uated in zebrafish embryos, it turned out to be more virulent
in adults, causing rapid development of necrotizing granulo-
mas accompanied by increased expression of proinflamma-
tory genes [29]. The different response of embryos and
adults to ESX-5 mutants is likely not mediated by the adap-
tive immune system, since ESX-5 mutants still have a
growth advantage over wild-type Mm in rag1-deficient
zebrafish. This study indicates that Mm relies on ESX-5-
mediated protein secretion for establishing persistent infec-
tion and highlights that parallel use of embryo and adult
zebrafish models can be important for unraveling mycobac-
terial virulence mechanisms [29].
TB in zebrafish embryos and larvae
The external fertilization of zebrafish eggs provides easy ac-
cess to developing embryos. Embryos naturally hatch by
2 days post fertilization (dpf), but the chorion can be removed
at 1 dpf to facilitate experimental infection. By 72 h post
fertilization (hpf), embryos reach the larval stage and larvae
become capable of independent feeding by 5 dpf [50]. During
this developmental time period, the primary functional im-
mune cell types are the macrophages and neutrophils; thus,
immunity relies on the innate arm of the system [51–53].
Embryos and larvae develop normally under anesthesia with
tricaine methane sulfonate (MS222), which makes them ideal
for non-invasive time lapse imaging. A growing collection of
fluorescent reporter lines facilitates the visualization of differ-
ent immune cell types, subcellular structures, and the activa-
tion of immune response genes [54]. Knockdown studies in
zebrafish embryos using antisense morpholino oligonucleo-
tides have strongly contributed to the understanding of early
mycobacterial pathogenesis [55–57]. In addition, randommu-
tagenesis screens proved a useful source of zebrafish mutants
for TB research [39, 58, 59]. Recent advances in gene
targeting technology should lead to an increased use of knock-
out lines in both embryo/larval and adult TB models [60, 61].
This will also enable gene disruption in a cell- or tissue-
specific manner, which until now has been a limitation of
the zebrafish model [62]. Zebrafish embryos and larvae are
particularly useful for screens of anti-TB drugs that can be
added simply to the medium [63, 64]. However, not all com-
pounds are efficiently taken up via the skin, and therefore,
drug efficacy in this system should be correlated with uptake
characteristics in order to eliminate false negatives and to en-
able better comparison with tests in mammalian models [65].
Systemic or localized infection of embryos and larvae can be
achieved bymicroinjectingMm bacteria at different sites, each
of which has specific advantages to address different research
questions (Fig. 1a) [66, 67].
Intravenous infection Systemic infection via the intravenous
route was used in the first description of the embryo TBmodel
and has since been the most frequently used [19]. The earliest
opportunity for intravenous infection is shortly after the onset
of blood circulation at 26 hpf, but microinjection into the
vascular system can also be performed at later stages [66,
67]. Mm bacteria delivered into the blood are predominantly
phagocytosed by macrophages [19, 68]. This is a rapid pro-
cess, with a dose of around 200 CFU being internalized within
30–60 min [69]. At 3 days post infection (dpi), infected and
non-infected macrophages are visible in tight granuloma-like
aggregates spread over the larval tissues but mostly occurring
in the proximity of blood vessels in the ventral part of the tail,
in the area of a temporary hematopoietic site, named the cau-
dal hematopoietic tissue (Fig. 1b, c) [19, 70, 71]. Most
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intravenously infected embryos also develop aggregates in
different areas of the brain, and this still occurs when bacteria
are injected at a later time point (4 dpf) when the blood brain
barrier has been formed [30]. Electron microscopy has shown
that some of the infected macrophages in larval granuloma-
like aggregates display an epithelioid morphology and that
multi-nucleate giant cells are present, which are distinctive
features of mature granulomas [19]. Furthermore, since Mm
bacteria in these aggregates express granuloma-specific fluo-
rescent reporter genes, the microenvironment appears to be
similar to that in mature granulomas [19, 70]. The environ-
ment of these larval granulomas has been shown to favor the
rapid development and dissemination of a multi-drug-tolerant
intracellularMm population [72]. Bacterial efflux pump inhib-
itors like verapamil can reduce this tolerance, demonstrating
that the system can be used for investigating the mechanisms
underlying tolerance and for therapeutic approaches to over-
come tolerance [72, 73]. Infection with labeled Mm strains
allows easy assessment of granuloma numbers, individual
granuloma sizes, and overall bacterial burden from fluores-
cence images, making the intravenous infection model well
suited to analyze the function of bacterial virulence factors and
host genes as well as for evaluating drug effects on granuloma
formation [57, 58, 64, 70, 74].
Yolk infection Injection of Mm into the yolk of developing
embryos between the 16–128 cell stage leads to an infection
that initially remains restricted to this area where macrophages
do not enter but from 3 dpi spreads by an unknown mecha-
nism into the larval tissues [75]. Once the infection spreads,
bacteria are taken up by macrophages and granulomas form
similar to those in the intravenous infection model. The yolk
injection method finds use in drug screening as it can be au-
tomated using a robotic injector [63, 65]. Using the yolk as
injection site, it has been shown that not onlyMm but alsoMtb
bacteria can spread into larval tissues and survive inside mac-
rophages [63]. Zebrafish are normally maintained at 28 °C,
but the temperature was increased to 34 °C to support growth
of Mtb. However, due to the slower growth of Mtb, the for-
mation of granuloma-like aggregates by infected macro-
phages has not been observed in zebrafish larvae.
Hindbrain ventricle infection The hindbrain ventricle
(fourth ventricle of the brain) is a cavity filled with cerebro-
spinal fluid into which macrophages can be recruited after
injection of bacteria or chemotactic proteins and lipids [51,
59, 76]. This is a convenient injection site to study host and
bacterial factors involved in chemotaxis or contributing to
dissemination of Mm [59, 76]. While a large bacterial cluster
develops locally in the hindbrain, macrophages can exit the
ventricle and carryMm to distal locations in the head, trunk, or
tail regions [59, 76, 77]. Hindbrain injection has also been
used to compare the ability of different strains to establish
infection in embryos that received low-dose inocula of 1–3
Mm bacteria, probably similar to the natural infection dose of
Mtb in human infections [76].
Fig. 1 Mm infection of zebrafish embryos. a Two-day-old zebrafish
embryo showing the different sites used for microinjection of Mm. The
developmental stages at which these injections are usually performed are
indicated between brackets. The location of trunk injection is similar to
that of subcutaneous injection but the microinjection needle is inserted
deeper into the tissue. b–c Confocal transmission (b) and fluorescence (c)
images showing a detail of the tail of a 5-day-old larvae with red
fluorescent Mm in granuloma-like aggregates at 4 dpi into the caudal
vein. d–e Granuloma with central necrosis in the tail fin of a zebrafish
larva at 5 dpi. Leukocytes detected by L-plastin antibody staining are
shown in green and Mm in red. Images show an overview of the tail fin
infection (d confocal transmission and fluorescence overlay) and a detail
of the granuloma (e confocal fluorescence)
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Otic vesicle infection Injection of bacteria into the cavity of
the developing ear is an alternative possibility to create a lo-
calized infection that is useful for studying leukocyte recruit-
ment and mobilization of macrophages and neutrophils at dis-
tal locations [59, 78].
Notochord infection The notochord consists of a longitudinal
column of vacuolated cells surrounded by a sheath of collagen
and serves as an embryonic skeleton prior to the formation of
bone. This structure is inaccessible to macrophages and neu-
trophils and hypersusceptible to Mm infection [79, 80]. The
virulence of anMm TesA mutant defective for major cell wall
lipids is retained in the notochord, while this mutant is strong-
ly attenuated when injected intravenously [79]. Since macro-
phages and neutrophils accumulate in the periphery of an in-
fected notochord, this model is useful for studying the host
inflammatory response [80]. It has also been suggested as a
model for the initial events characterizing bone tuberculosis
[79].
Subcutaneous infection When Mm is injected into fluid-
filled compartments, such as the blood or hindbrain ventricle,
phagocytosis is dominated by macrophages [68, 77]. Howev-
er, neutrophils play a major role in phagocytosis of
mycobacteria in other models as well as in human TB infec-
tion [81, 82]. Neutrophils require a surface for efficient phago-
cytosis and have been shown to take up Mm bacteria when
injected subcutaneously into zebrafish larvae [83, 84]. There-
fore, subcutaneous injection or injection into other tissues
such as muscle or the tail fin (described below) is useful to
address the contribution of neutrophils to the early stages of
mycobacterial pathogenesis [84–86].
Tail fin infection The larval tail fin consists of two epithelial
cell layers on both sides with mesenchymal cells, extracellular
matrix, and collagenous fibers in between. Injection of Mm
into the tail fin results in the rapid attraction of macrophages
and neutrophils and formation of a single granulomatous le-
sion [86]. This method enables visualizing the process of
granuloma development from the first infected cell to the stage
where a necrotic center is formed. The necrotic center is even-
tually extruded from the thin tissue of the tail fin, resulting in
central pore (Fig. 1d, e) [86]. This thin tissue is very suitable
for high-resolution microscopic imaging and has been used
for correlative fluorescence and electron microscopy analysis
of the formation of autophagic vesicles during Mm infection
[86].
Trunk infection Injection ofMm into the dorsal region of the
trunk leads to the formation of primary granulomas that grow
larger than granulomas in other more vascularized areas and
that develop local hypoxia. The trunk is therefore a preferred
injection site for studying the association between granuloma
formation and angiogenesis [31]. Trunk granulomas attract
new vessels sprouting from the existing intersegmental ves-
sels, and this response can be inhibited either by genetic de-
pletion of macrophages or by pharmacological inhibition of
the Vegf receptor. Blockade of Vegf signaling also reduces
vascular leakiness, dissemination ofMm, and overall bacterial
burden. Production of Vegf is independent of hypoxia devel-
opment, and macrophages on the edges of the developing
granulomas are proposed to be the source of this
proangiogenic signaling molecule [31].
Roles of macrophages and neutrophils during early
pathogenesis
Genetic depletion of macrophages during embryo develop-
ment showed that macrophages limit the growth of Mm, yet
are essential for the dissemination of Mm into tissues [77].
Macrophages phagocytose Mm in a manner partially depen-
dent on the conserved scavenger receptor Marco [69]. Several
factors have be shown to be involved in the containment of
infection bymacrophages in zebrafish, including tumor necro-
sis factor (Tnf), autophagy components (P62/Sqstm1 and
Dram1), and a macrophage-specific perforin (Mpeg1) [57,
87, 88]. In contrast, Mm bacteria seem to be able to evade
reactive oxygen or nitrogen-mediated defenses [56, 76, 89].
Mm bacteria initially replicate inside membrane-enclosed
compartments of macrophages from which they eventually
escape in a manner requiring the ESX-1 secretion system
[57, 86]. By a mechanism also requiring ESX-1, uninfected
macrophages in the vicinity of infected cells polarize, increase
their motility, and scavenge dying infected cells, thereby driv-
ing expansion of the granuloma [20]. The ESX-1-secreted
factor ESAT6 is thought to act as a signal that induces epithe-
lial cells to secrete the matrix metalloproteinase Mmp9, facil-
itating the recruitment of macrophages and expansion of gran-
ulomas (Fig. 2) [55]. Rifampicin-loaded nanoparticles are rap-
idly taken up by macrophages and reduce bacterial load of
zebrafish larvae, showing that the property of macrophages
to be recruited to granulomas can be exploited for drug deliv-
ery [71]. It remains to be elucidated how macrophages can
reverse migrate and egress from granulomas to disseminate
Mm, and future work in zebrafish larvae may help to answer
this question [20, 54, 59].
Zebrafish embryo/larval models are also helping to clarify
the role of neutrophils during early mycobacterial pathogene-
sis. Bacteremia preceding the death of larvae at later stages of
Mm infection is associated with neutropenia, suggesting that
depletion of neutrophils affects the ability to control infection
[84]. In agreement, increased bacterial burden is observed in a
zebrafish transgenic line ectopically expressing a gain-of-
function truncation of chemokine receptor Cxcr4 that causes
retention of neutrophils in the hematopoietic tissues [68, 90].
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In wild-type larvae, neutrophils attracted to granulomas
around 3 dpi have been observed to phagocytose dying infect-
ed macrophages. A subset of these neutrophils is able to kill
intracellular Mm through NADPH oxidase-mediated reactive
oxygen production [68]. At earlier stages of infection, when
Mm is mostly restricted to macrophages, uninfected neutro-
phils respond by production of nitric oxide, detected by in-
creased levels of nitrotyrosine [91]. However, this response is
not an effective defense mechanism, since blocking of induc-
ible nitric oxide synthase (iNos/Nos2a) has no effect on the
ability to control Mm infection. In contrast, host defense is
enhanced when the nitric oxide response of neutrophils is
artificially upregulated prior to infection, not allowing the
bacteria time to adapt. This can be achieved by genetic or
pharmacologic manipulation of hypoxia-inducible factor
(Hif-α) signaling, suggesting this pathway as a potential
host-therapeutic target [89, 91]. That neutrophils contribute
to early host defense against mycobacteria is supported by
studies in other animal models, but there is also much evi-
dence for a pathological role of neutrophils in driving inflam-
mation and progression of TB disease [82, 92–94].
Mycobacterial avoidance and exploitation
of Toll-like and chemokine receptor responses
Zebrafish embryos carrying a mutation in Myd88, the com-
mon adaptor of Toll-like and interleukin-1/18 receptors, show
increased susceptibility to Mm infection following intrave-
nous injection [39, 76]. In this systemic infection model,
Myd88 deficiency has been shown to impact onmultiple path-
ways of innate host defense against Mm, including cytokine-
mediated, nitrosative, and autophagic defense mechanisms
[39, 57, 89]. In contrast, it has been found that Myd88 is not
required for the initial recruitment of macrophages in a local
hindbrain infection model, indicating that mycobacteria have
evolved mechanisms to avoid TLR/Myd88-mediated de-
fenses [76]. Mycobacterial cell wall lipids have been implicat-
ed in this immune evasion strategy, notably the phthiocerol
dimycocerosates (PDIM) known to be major virulence factors
of pathogenic mycobacteria. PDIM-deficient Mm strains or
other bacterial species not containing PDIM (Mycobacterium
smegmatis , Staphylococcus aureus , Pseudomonas
aeruginosa) trigger a TLR/Myd88-dependent response.
Zebrafish macrophages recruited to these strains show a mi-
crobicidal iNos-positive phenotype, while macrophages re-
cruited to PDIM-expressing Mm are iNos negative. In agree-
ment, PDIM-deficient Mtb attract a higher number of iNos-
positive cells in lung tissue of mice compared with H37Rv
Mtb [76]. These findings led to an interestingmodel proposing
that pathogenic mycobacteria use PDIM to mask the underly-
ing TLR ligands and thereby establish infection in a permis-
sive macrophage population that is encountered in the lower
respiratory tract whereMtb is known to initiate infection rather
than in the upper tract where TLR/Myd88-dependent macro-
phage polarization is induced by the presence of resident mi-
croflora and inhaled environmental microbes [76, 95]. Besides
this role in masking TLR recognition, PDIM lipids are likely
to impact directly on the microbicidal activity of macrophages
through their capacity to insert into the plasma membrane and
into the membranes of intracellular compartments where
mycobacteria replicate [96].
The CCL2-CCR2 chemokine signaling axis has been
linked to the recruitment of permissive macrophages by
PDIM-containing Mm, in a manner dependent on phenolic
glycolipids (PGLs) [76]. CCR2 is required for the mobiliza-
tion of monocytes from the bone marrow and their trafficking
to sites of inflammation [97]. Consequently, in murine models
of infectious diseases, including TB, CCR2 deficiency impairs
host defense [98–100]. However, as pointed out by Cambier
et al., experimental infections using high inocula may have
failed to reveal how mycobacteria can exploit CCL2-CCR2
signaling to establish infection under clinically relevant low
inoculum conditions [76]. While CCL2 is generally consid-
ered an inflammatory chemokine, there is evidence that it can
shif t the polarizat ion of macrophages toward an
antiinflammatory phenotype [101]. This is consistent with
the model proposing that CCL2-CCR2 signaling promotes
mycobacterial infectivity under low inoculum conditions and
with a genetic association study correlating high expression of
CCL2 with TB susceptibility [76, 102].
Mutation of cxcr3.2, one of three zebrafish homologs of the
human CXCR3 receptor, has a similar effect on macrophage
recruitment to Mm infection in the zebrafish hindbrain injec-
tion model as knockdown of Ccl2-Ccr2 signaling [59]. It is
currently not known if these two chemokine-mediated recruit-
ment mechanisms act redundantly or in a concerted manner.
Fig. 2 Signals involved in early granuloma formation. Studies in
zebrafish suggest that mycobacteria (red) inside infected macrophages
(blue) secrete the ESAT6 virulence factor, which, in turn, induces
nearby epithelial cells (brown) to secrete the matrix metalloproteinase
Mmp9 that is thought to facilitate the migration of macrophages [55].
This matrix degradation pathway could act cooperatively with Cxcr3-
Cxcl11 signaling between infected and uninfected macrophages
promoting the chemoattraction of macrophages and their aggregation
into initial granulomas [59]
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The interferon-γ-inducible inflammatory chemokines
CXCL9, 10, and 11, the ligands of human CXCR3, show
enhanced plasma levels in TB patients, and CXCR3 ligands
are also expressed in pulmonary granulomas of Mtb-infected
cynomolgus macaques [103, 104]. Besides reducing macro-
phage recruitment in response to locally injectedMm bacteria
or Cxcl11-like chemokines, cxcr3.2 mutation also results in
other phenotypes suggesting that mycobacteria use CXCR3
signaling to their advantage. First, cxcr3.2 mutation reduces
dissemination of Mm from the hindbrain ventricle to other
regions of the head, trunk, and tail. Second, cxcr3.2 mutation
reduces the expansion of granulomas, either those resulting
from disseminated local infection or those resulting from sys-
temic intravenous infection. Third, cxcr3.2-deficient macro-
phages have reduced basal motility. Although this motility
defect can be overcome by delivering Cxcr3.2-independent
stimuli, it might limit spreading of mycobacteria between
macrophages in granulomas (Fig. 2) [59]. A host-beneficial
effect of disrupting the CXCR3 axis is not limited to the con-
text of macrophage function in zebrafish larvae. CXCR3-defi-
cient mice control chronicMtb infection better than wild-type
animals, and this has been attributed to an adverse effect on T
cell priming [105]. In another study, it has been shown that
CXCR3-deficient mice are delayed in granuloma formation
similar to neutrophil-depleted mice in which the expression
of CXCR3 signaling chemokines is diminished [106]. It has
recently been suggested that CXCR3 deficiency in mice is
linked with polarization of macrophages toward an iNos-neg-
ative, antiinflammatory phenotype [107, 108]. If such polari-
zation would occur in the context of mycobacterial infection,
this would make macrophages more permissive for bacterial
growth, which is contrast with the host-beneficial effect of
CXCR3 deficiency in both zebrafish and murine TB models.
Together, these studies indicate that, rather than iNos-
mediated defense, other CXCR3-dependent mechanisms are
important for control of mycobacterial infection and support
further investigation of the CXCR3-CXCL11 axis as a host
therapeutic target for TB treatment [59, 105, 106].
It currently remains unanswered if there are pre-existing
macrophage subsets in zebrafish embryos responding to
Ccl2- or Cxcl11-like chemokines andMyd88-dependent cues,
or if these signals might drive different polarization of recruit-
ed macrophages. The source of the chemoattractants also re-
mains to be established. Two not mutually exclusive origins of
infection-inducible chemokines are the neuroepithelial cells
lining the hindbrain ventricle or the macrophages themselves.
Few macrophages can be resident in the cavity prior to injec-
tion or are initially attracted independent of the bacterial pres-
ence due to a minor wounding effect that is unavoidable in this
assay. In situ mRNA detection of the chemokines and their
receptors is unfortunately limited by low expression levels.
However, RNAseq of leukocyte populations isolated by
fluorescent-activated cell sorting suggests that macrophages
could indeed be the source of both CCL and CXCL
chemokines [109 and unpublished results].
Protective and pathological roles of inflammation
The dual role that inflammation plays in TB pathogenesis is
extensively discussed in recent reviews [10, 110, 111]. Con-
sistent with many studies in other animal models, zebrafish
larvae are found to be hypersusceptible toMm infection either
when inflammation fails or when the inflammatory response
is exacerbated [39, 56, 58, 87, 112–114]. The optical transpar-
ency of zebrafish larvae has helped to distinguish whether
defects in inflammation affect the early formation of granulo-
mas or their maintenance. Knockdown of the Tnf receptor in
zebrafish accelerates granuloma formation but leads to rapid
breakdown of granulomas and extracellular growth of Mm
[87]. Limited Tnf production leads to the same phenotype,
supporting that Tnf is dispensable for granuloma formation
but critical for the maintenance of granuloma integrity [58].
Increased expansion of Mm granulomas in Myd88-deficient
zebrafish larvae agrees with these findings [39, 76]. However,
it is likely that multiple factors contribute to this phenotype,
since lack of Myd88-dependent signaling reduces not only tnf
gene expression but also the expression of other major cyto-
kine and defense genes [39, 57, 88].
A zebrafish mutagenesis screen uncovered an intricate
cross talk between cytokine and lipid mediators of inflamma-
tion during Mm infection [58]. In hypersusceptible lta4h mu-
tants, deficiency in leukotriene A4 hydrolase redirects eicos-
anoid intermediates into the production of antiinflammatory
lipoxins, which, in turn, limits Tnf production [58]. Other
intersections between the cytokine and eicosanoid networks
have recently been revealed, notably the production of pros-
taglandin E2 (PGE2) driven by IL-1, which promotes the con-
trol of Mtb infection [115]. It is now widely believed that a
better understanding of the complexity of this interplay holds
promise for immunotherapeutic interventions using clinically
approved drugs to carefully manipulate the cytokine/
eicosanoid balance in TB patients [110, 111, 115].
A hyperinflamed status can be induced in zebrafish lar-
vae by injection of recombinant TNF, by overexpression of
the leukotriene biosynthetic enzyme Lta4h, or by knock-
down of the non-receptor tyrosine phosphatase Ptpn6, a
negative regulator of inflammation [56, 88, 112, 113]. In
all cases, this results in hypersusceptibility to Mm infection,
underscoring the importance of a balanced inflammatory
response. Mechanistically, the detrimental effect of high
levels of Tnf in zebrafish has been attributed to the mode
of cell death of Mm-infected macrophages in this situation
[56]. Excess Tnf triggers the production of mitochondrial
reactive oxygen species through Rip1-Rip3-dependent sig-
naling, and this induces a programmed type of necrotic cell
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death. This necroptotic cell death is mediated by
cyclophilin D, which is involved in formation of the mito-
chondrial permeability transition pore complex and by the
lysosomal acid sphingomyelinase, which is required for
ceramide production. Pharmacological inhibition of these
two pathways prevents initiation of the necroptotic program
and reverses the hypersusceptibility of zebrafish larvae with
high Tnf levels [56]. In the case of low Tnf levels, macro-
phages likely undergo passive necrosis with a similar exac-
erbating effect on Mm infection as the induction of the
necroptotic pathway [87]. These results are in line with
evidence that virulence factors of Mtb trigger necrotic cell
death of macrophages, while inhibiting the immunological-
ly silent apoptotic cell death program [116]. Besides TNF,
lipid mediators are crucial for the mode of cell death, with
necrosis being promoted by antiinflammatory lipoxins and
inhibited by PGE2 [117]. These recent insights in the im-
pact of the cell death program on the outcome of myco-
bacterial infection have important therapeutic implications
[116]. Zebrafish larvae are a useful model to test cell death
modulators in vivo, since mechanisms of cell death appear
to be strongly evolutionary conserved [56].
Protective role of autophagy
The recognition of autophagy as an innate host defense
mechanism against intracellular pathogens started with
the observation that stimulation of autophagy by nutrient
starvation or rapamycin treatment could overcome the
Mtb-induced block in phagolysosome maturation [118,
119]. Since then, a number of siRNA and chemical
screens in Mtb- or BCG-infected cells have pointed to-
ward autophagy as a therapeutic target for TB treatment
[120–123]. During autophagy (or macroautophagy), protein
aggregates, organelles or intracellular bacteria become
enclosed in autophagosomes characterized by a double
membrane and the marker protein Lc3. This can be a
non-specific bulk process or a selective process mediated
by specific cargo receptors, such as the ubiquitin receptors
p62 (sequestosome 1), optineurin, and ndp52 [119]. Selec-
tive autophagy by the receptor-mediated pathway requires
that mycobacteria escape from the phagosomal compart-
ment or induce damage to the phagosomal membrane per-
mitting them to be ubiquitinated (Fig. 3). A functional
ESX-1 secretion system is required for the rupture of
phagosomes and ubiquitination of mycobacteria [124,
127, 128]. However, ESX-1-deficient BCG bacteria are
also sensitive to autophagy stimulation, indicating that
mycobacteria can be targeted to autophagy via multiple
mechanisms that may include sequestering of complete
phagosomes by autophagosomal isolation membranes, the
recruitment of Lc3 to phagosomes (Lc3-associated
phagocytosis), or the formation of amphisomes through
the fusion between autophagosomes and endosomes [118,
129, 130]. In zebrafish larvae, the escape-dependent au-
tophagy route appears to predominate and ESX-1-
deficient Mm fail to recruit Lc3 [57, 86]. Confocal imag-
ing of GFP-Lc3 transgenic zebrafish combined with elec-
tron microscopy has confirmed the presence of wild-type
Mm in compartments with autophagic morphology [86].
Approximately two thirds of GFP-Lc3-positive Mm-con-
taining vesicles in leukocytes of larval tail fin granulomas
stain positive for a lysosomal marker [86]. Furthermore,
imaging in zebrafish has revealed the frequent presence
of small GFP-Lc3 vesicles in close vicinity of bacteria
or bacterial aggregates [57, 86]. These vesicles might
serve to deliver neo-antimicrobial peptides to the Mm-con-
taining compartments, a process that has been shown to
augment the bactericidal properties of autophagic organ-
elles in Mtb-infected cells (Fig. 3) [126].
Rapamycin induces autophagy via mTOR kinase but also
leads to immunosuppression [131]. While promoting intracel-
lular killing of Mtb in vitro, rapamycin is detrimental to
zebrafish host defense against Mm [57, 118]. Interestingly, a
recent screen for mTOR-independent inducers of autophagy
has shown that a clinically approved anticonvulsant drug, car-
bamazepine, triggers autophagy by a novel myo-inositol de-
pendent pathway and is effective in vivo, both against Mtb in
mice and against Mm in zebrafish [122]. Another potential
therapeutic target is the DRAM1-mediated autophagy path-
way that we have recently found to protect against Mm infec-
tion in zebrafish (Fig. 3) [57, 125]. DRAM1 is a DNA
Fig. 3 Dram1-modulated autophagic defense pathway in
macrophages. Following infection of zebrafish embryos, Mm bacteria
are detected inside membrane compartments of macrophages as well as
freely in the cytoplasm [57, 86]. Translocation ofMm to the cytoplasm is
dependent on the ESX-1 secretion system required for rupture of the
phagosome membrane (dashed line). By analogy with studies of Mtb in
cultured macrophages,Mm bacteria escaping the phagosome are thought
to be ubiquitinated by a STING-dependent pathway and targeted to
selective autophagy mediated by ubiquitin receptors [57, 124]. DRAM1
is induced during infection by Myd88-NFκB signaling and proposed to
promote the formation of autophagosomes as well as multiple vesicle
fusion events between autophagosomes and lysosomes leading to the
formation of larger degradative compartments [57, 125]. The
microbicidal properties of these compartments could be enhanced due
to the delivery of ubiquitinated peptides by autophagosomes [126]
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damage-regulated autophagy modulator previously implicat-
ed in p53-mediated cell death [132]. During Mm infection in
zebrafish, the induction of dram1 gene expression is directly
linked with innate immunity, as it is independent of p53 and
partially dependent on Myd88. Infection of human macro-
phages further placed NFκB upstream of DRAM1 gene ex-
pression and demonstrated colocalization of DRAM1 protein
with Mtb [57]. Deficiency in either Myd88 or Dram1 re-
duces GFP-Lc3 recruitment to Mm in zebrafish and impairs
the ability to containMm insidemacrophages. Overexpression
of Dram1 has the opposite effect, promoting the intracellular
killing of Mm in zebrafish through enhanced autophagosome
formation and autophagic flux [57]. This Dram1-mediated
enhancement of autophagy requires the function of the ubiq-
uitin receptor p62 and the stimulator of interferon genes,
Sting (Tmem173), previously implicated in the ESX-1-
dependent autophagic response to Mtb [124]. DRAM1 induc-
tion is associated with the type I interferon-responsive gene
signature of human patients with active TB [57, 93]. Recent
work shows that cyclic GMP-AMP synthase (cGAS) forms
the mechanistic link between the production of type I inter-
ferons and the activation of autophagy [133–135]. cGAS
functions as a cytosolic sensor of Mtb DNA, resulting in the
production of cGAMP as a second messenger that activates
STING and interferon production [133–135]. cGAS is also
required for autophagic targeting of Mtb and cGAS-deficient
mice are more susceptible toMtb infection [133, 135]. There-
fore, despite that the type I interferon response is generally
associated with inflammation and disease progression, the
same mechanism that triggers this response also activates es-
sential antibacterial functions. The mechanism by which
DRAM1 may stimulate the cGAS-dependent autophagic
targeting of mycobacteria will require further studies that
hopefully will also provide new clues for host-directed anti-
TB therapy.
Concluding remarks
The main strength of the zebrafish model for TB research is
the optical access in embryos and larvae to the early stages of
granulomas that develop in the context of innate immunity.
The ease of genetic and pharmacological manipulation in em-
bryos and larvae has helped to gain better understanding of the
roles of macrophages and neutrophils in early pathogenesis
and has revealed molecular mechanisms that are exploited
by virulent mycobacteria to promote their expansion and dis-
semination inside the infected host. It can be expected that
zebrafish embryos and larvae will also prove useful for
in vivo investigation of the epigenetic mechanisms underlying
trained innate immunity, which has recently emerged as a new
concept in immunology [136]. Trained innate immunity has
been implicated in non-specific protective effects of the BCG
vaccine against non-mycobacterial diseases and cancers and
could also play an important role in tuberculosis [137]. Au-
tophagy is another new immunological paradigm, critical for
defense against mycobacteria and also linked with trained
innate immunity [119, 138]. In vivo visualization of the au-
tophagic response to mycobacteria in zebrafish larvae has
supported many previous in vitro studies that pointed to the
central role of autophagy in host defense [57, 86]. Despite
limitations in immunological reagents and characterization
of the adaptive immune system, adult zebrafish also are a
useful addition to TB research, in particular because of the
similarities in the structure of fish and human TB granulomas
[14, 15, 35]. Zebrafish models are now increasingly applied
for translational research into host-directed therapies for tuber-
culosis [5, 9, 10, 54, 139]. Potential drug targets emerging
from this work include pathways involved in macrophage
migration, inflammation, cell death regulation, hypoxia sig-
naling, angiogenesis, and mTOR-independent autophagy [31,
55–59, 91, 112, 122]. Targeting the host avoids direct selec-
tive pressure on bacteria and therefore has lower risk of drug
resistance development [5]. However, possible side effects on
the host are a major concern. In view of the many useful
characteristics discussed above, zebrafish can play an impor-
tant role in assessing developmental toxicity and characteriz-
ing the mechanisms of drug action in vivo.
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